Comparative Safety and Effectiveness of Apixaban Dosing in Patients With Atrial Fibrillation and Severe CKD

被引：0
|
作者：
Xu, Yunwen [1 ]
Chang, Alex R. [2 ]
Inker, Lesley A. [3 ]
McAdams-DeMarco, Mara [4 ]
Grams, Morgan [1 ,4 ]
Shin, Jung-Im [1 ]
机构：
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] Geisinger Hlth, Danville, PA USA
[3] Tufts Med CTR, Boston, MA USA
[4] NYU, Grossman Sch Med & Langone Hlth, New York, NY USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO896
引用
收藏
页码：305 / 305
页数：1
相关论文
共 50 条
  • [21] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
    Martinez, Brandon K.
    Sood, Nitesh A.
    Bunz, Thomas J.
    Coleman, Craig I.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [22] EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN FRAIL PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Coleman, Craig I.
    Turpie, Alexander
    Bunz, Thomas J.
    Sood, Nitesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 290 - 290
  • [23] Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study
    Al Sulaiman, Khalid
    Badreldin, Hisham A.
    Korayem, Ghazwa B.
    Alenazi, Abeer A.
    Alsuwayyid, Faisal
    Alrashidi, Abdulrahman
    Alhijris, Mohammed
    Almutairi, Faisal
    Alharthi, Fahad
    Vishwakarma, Ramesh
    Al Shaya, Omar
    Al Amri, Abdulrahman
    Tayyab, Saqiba
    Al Bekairy, Abdulkareem M.
    Aljuhani, Ohoud
    THROMBOSIS JOURNAL, 2022, 20 (01)
  • [24] COST EFFECTIVENESS OF APIXABAN COMAPRED TO ASPIRIN IN PATIENTS WITH ATRIAL FIBRILLATION
    Ademi, Z.
    Pasupathi, K.
    Liew, D.
    VALUE IN HEALTH, 2014, 17 (03) : A117 - A117
  • [25] Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients With Nonvalvular Atrial Fibrillation Treated in Routine German Practice
    Coleman, Craig I.
    Peacock, W. Frank
    Antz, Matthias
    HEART LUNG AND CIRCULATION, 2018, 27 (03): : 390 - 393
  • [26] Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study
    Grymonprez, Maxim
    De Backer, Tine L. L.
    Bertels, Xander
    Steurbaut, Stephane
    Lahousse, Lies
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [27] Using real-world data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK
    Gibbs, Liza
    Govil, Priya
    Kent, Seamus
    Duffield, Stephen
    Rowark, Shaun
    Sharma, Manuj
    Ali, Ayad
    Patrick, Amanda
    Jaksa, Ashley
    Jonsson, Pall
    Gatto, Nicolle
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 74 - 74
  • [28] Efficacy and Safety of Apixaban in the Patients Undergoing the Ablation of Atrial Fibrillation
    Nagao, Tomoyuki
    Inden, Yasuya
    Shimano, Masayuki
    Fujita, Masaya
    Yanagisawa, Satoshi
    Kato, Hiroyuki
    Ishikawa, Shinji
    Miyoshi, Aya
    Okumura, Satoshi
    Ohguchi, Shiou
    Yamamoto, Toshihiko
    Yoshida, Naoki
    Hirai, Makoto
    Murohara, Toyoaki
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (02): : 155 - 163
  • [29] Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation
    Flaker, Greg
    Lopes, Renato D.
    Al-Khatib, Sana M.
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Tinga, Brian
    Zhu, Jun
    Mohan, Puneet
    Garcia, David
    Bartunek, Jozef
    Vinereanu, Dragos
    Husted, Steen
    Harjola, Veli Pekka
    Rosenqvist, Marten
    Alexander, John H.
    Granger, Christopher B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (11) : 1082 - 1087
  • [30] Apixaban in Patients with Atrial Fibrillation
    Connolly, Stuart J.
    Eikelboom, John
    Joyner, Campbell
    Diener, Hans-Christoph
    Hart, Robert
    Golitsyn, Sergey
    Flaker, Greg
    Avezum, Alvaro
    Hohnloser, Stefan H.
    Diaz, Rafael
    Talajic, Mario
    Zhu, Jun
    Pais, Prem
    Budaj, Andrzej
    Parkhomenko, Alexander
    Jansky, Petr
    Commerford, Patrick
    Tan, Ru San
    Sim, Kui-Hian
    Lewis, Basil S.
    Van Mieghem, Walter
    Lip, Gregory Y. H.
    Kim, Jae Hyung
    Lanas-Zanetti, Fernando
    Gonzalez-Hermosillo, Antonio
    Dans, Antonio L.
    Munawar, Muhammad
    O'Donnell, Martin
    Lawrence, John
    Lewis, Gayle
    Afzal, Rizwan
    Yusuf, Salim
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09): : 806 - 817
12345